Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.

Gharzai LA, Green MD, Griffith KA, Else T, Mayo CS, Hesseltine E, Spratt DE, Ben-Josef E, Sabolch A, Miller BS, Worden F, Giordano TJ, Hammer GD, Jolly S.

J Clin Endocrinol Metab. 2019 Sep 1;104(9):3743-3750. doi: 10.1210/jc.2019-00029.

PMID:
31220287
2.

Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New American Joint Committee on Cancer Eighth Edition Criteria for Tumor Staging.

Turk AT, Asa SL, Baloch ZW, Faquin WC, Fellegara G, Ghossein RA, Giordano TJ, LiVolsi VA, Lloyd R, Mete O, Rosai J, Suster S, Thompson LDR, Wenig BM.

Thyroid. 2019 May;29(5):619-624. doi: 10.1089/thy.2018.0286. Epub 2019 Apr 27.

PMID:
30913992
3.

Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma.

Mohan DR, Lerario AM, Else T, Mukherjee B, Almeida MQ, Vinco M, Rege J, Mariani BMP, Zerbini MCN, Mendonca BB, Latronico AC, Marie SKN, Rainey WE, Giordano TJ, Fragoso MCBV, Hammer GD.

Clin Cancer Res. 2019 Jun 1;25(11):3276-3288. doi: 10.1158/1078-0432.CCR-18-2693. Epub 2019 Feb 15.

PMID:
30770352
4.

Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants.

Lerario AM, Nanba K, Blinder AR, Suematsu S, Omura M, Nishikawa T, Giordano TJ, Rainey W, Else T.

Endocr Relat Cancer. 2019 Apr 1;26(4):463-470. doi: 10.1530/ERC-18-0364. Epub 2019 Feb 1.

PMID:
30753137
5.

Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Nanba K, Omata K, Gomez-Sanchez CE, Stratakis CA, Demidowich AP, Suzuki M, Thompson LDR, Cohen DL, Luther JM, Gellert L, Vaidya A, Barletta JA, Else T, Giordano TJ, Tomlins SA, Rainey WE.

Hypertension. 2019 Apr;73(4):885-892. doi: 10.1161/HYPERTENSIONAHA.118.12070.

PMID:
30739536
6.

Somatic mutations in adrenocortical carcinoma with hyperaldosteronism.

Mouat IC, Omata K, McDaniel AS, Hattangady N, Talapatra D, Cani AK, Hovelson DH, Tomlins SA, Rainey W, Hammer G, Giordano TJ, Else T.

Endocr Relat Cancer. 2018 Nov 1. pii: ERC-18-0385.R2. doi: 10.1530/ERC-18-0385. [Epub ahead of print]

PMID:
30475217
7.

Longitudinal patterns of recurrence in patients with adrenocortical carcinoma.

Glenn JA, Else T, Hughes DT, Cohen MS, Jolly S, Giordano TJ, Worden FP, Gauger PG, Hammer GD, Miller BS.

Surgery. 2019 Jan;165(1):186-195. doi: 10.1016/j.surg.2018.04.068. Epub 2018 Oct 19.

PMID:
30343951
8.

[Update of WHO classification of the tumors of adrenal gland in 2017].

Su P, Liu ZY, Giordano TJ.

Zhonghua Bing Li Xue Za Zhi. 2018 Oct 8;47(10):804-807. doi: 10.3760/cma.j.issn.0529-5807.2018.10.020. Chinese. No abstract available.

PMID:
30317745
9.

Transcriptional targeting of oncogene addiction in medullary thyroid cancer.

Valenciaga A, Saji M, Yu L, Zhang X, Bumrah C, Yilmaz AS, Knippler CM, Miles W, Giordano TJ, Cote GJ, Ringel MD.

JCI Insight. 2018 Aug 23;3(16). pii: 122225. doi: 10.1172/jci.insight.122225. eCollection 2018 Aug 23.

10.

Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.

Nanba K, Omata K, Else T, Beck PCC, Nanba AT, Turcu AF, Miller BS, Giordano TJ, Tomlins SA, Rainey WE.

J Clin Endocrinol Metab. 2018 Oct 1;103(10):3869-3876. doi: 10.1210/jc.2018-01004.

11.

65 YEARS OF THE DOUBLE HELIX: Classification of endocrine tumors in the age of integrated genomics.

Giordano TJ.

Endocr Relat Cancer. 2018 Aug;25(8):T171-T187. doi: 10.1530/ERC-18-0116. Review.

PMID:
29980645
12.

Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features.

Nikiforov YE, Baloch ZW, Hodak SP, Giordano TJ, Lloyd RV, Seethala RR, Wenig BM.

JAMA Oncol. 2018 Aug 1;4(8):1125-1126. doi: 10.1001/jamaoncol.2018.1446. No abstract available.

13.

Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Mete O, Asa SL, Giordano TJ, Papotti M, Sasano H, Volante M.

Endocr Pathol. 2018 Jun;29(2):137-149. doi: 10.1007/s12022-018-9525-8. Review.

PMID:
29542002
14.

Pioglitazone Therapy of PAX8-PPARγ Fusion Protein Thyroid Carcinoma.

Giordano TJ, Haugen BR, Sherman SI, Shah MH, Caoili EM, Koenig RJ.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1277-1281. doi: 10.1210/jc.2017-02533.

15.

Genomic Hallmarks of Thyroid Neoplasia.

Giordano TJ.

Annu Rev Pathol. 2018 Jan 24;13:141-162. doi: 10.1146/annurev-pathol-121808-102139. Epub 2017 Oct 30. Review.

PMID:
29083981
16.

The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.

Udager AM, Magers MJ, Goerke DM, Vinco ML, Siddiqui J, Cao X, Lucas DR, Myers JL, Chinnaiyan AM, McHugh JB, Giordano TJ, Else T, Mehra R.

Hum Pathol. 2018 Jan;71:47-54. doi: 10.1016/j.humpath.2017.10.013. Epub 2017 Oct 24.

PMID:
29079178
17.

Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells.

Sundaresan S, Meininger CA, Kang AJ, Photenhauer AL, Hayes MM, Sahoo N, Grembecka J, Cierpicki T, Ding L, Giordano TJ, Else T, Madrigal DJ, Low MJ, Campbell F, Baker AM, Xu H, Wright NA, Merchant JL.

Gastroenterology. 2017 Dec;153(6):1555-1567.e15. doi: 10.1053/j.gastro.2017.08.038. Epub 2017 Aug 30.

18.

Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism.

Nanba AT, Nanba K, Byrd JB, Shields JJ, Giordano TJ, Miller BS, Rainey WE, Auchus RJ, Turcu AF.

Clin Endocrinol (Oxf). 2017 Dec;87(6):665-672. doi: 10.1111/cen.13442. Epub 2017 Sep 4.

19.

Recurrent Hyperparathyroidism Due to a Novel CDC73 Splice Mutation.

Hattangady NG, Wilson TL, Miller BS, Lerario AM, Giordano TJ, Choksi P, Else T.

J Bone Miner Res. 2017 Aug;32(8):1640-1643. doi: 10.1002/jbmr.3149. Epub 2017 Jun 2.

20.

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS; Cancer Genome Atlas Research Network, Pacak K, Nathanson KL, Wilkerson MD.

Cancer Cell. 2017 Feb 13;31(2):181-193. doi: 10.1016/j.ccell.2017.01.001. Epub 2017 Feb 2.

21.

Genetic variants in thyroid cancer distant metastases.

Justiniano SE, McElroy JP, Yu L, Yilmaz AS, Coombes KR, Senter L, Nagy R, Wakely P Jr, Volinia S, Vinco M, Giordano TJ, Croce CM, Saji M, Ringel MD.

Endocr Relat Cancer. 2016 Oct;23(10):L33-6. doi: 10.1530/ERC-16-0351. Epub 2016 Aug 19. No abstract available.

22.

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW.

Cancer Cell. 2016 Aug 8;30(2):363. doi: 10.1016/j.ccell.2016.07.013. Epub 2016 Aug 8. No abstract available.

23.

Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations.

Wylie D, Beaudenon-Huibregtse S, Haynes BC, Giordano TJ, Labourier E.

J Pathol Clin Res. 2016 Feb 8;2(2):93-103. doi: 10.1002/cjp2.38. eCollection 2016 Apr.

24.

Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma.

Liu-Chittenden Y, Patel D, Gaskins K, Giordano TJ, Assie G, Bertherat J, Kebebew E.

J Clin Endocrinol Metab. 2016 Sep;101(9):3345-52. doi: 10.1210/jc.2016-1781. Epub 2016 Jun 23.

25.

Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.

Nanba K, Omata K, Tomlins SA, Giordano TJ, Hammer GD, Rainey WE, Else T.

Eur J Endocrinol. 2016 Aug;175(2):K1-6. doi: 10.1530/EJE-16-0262. Epub 2016 May 10.

26.

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW.

Cancer Cell. 2016 May 9;29(5):723-736. doi: 10.1016/j.ccell.2016.04.002. Erratum in: Cancer Cell. 2016 Aug 8;30(2):363.

27.

EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression.

Drelon C, Berthon A, Mathieu M, Ragazzon B, Kuick R, Tabbal H, Septier A, Rodriguez S, Batisse-Lignier M, Sahut-Barnola I, Dumontet T, Pointud JC, Lefrançois-Martinez AM, Baron S, Giordano TJ, Bertherat J, Martinez A, Val P.

Hum Mol Genet. 2016 Jul 1;25(13):2789-2800. Epub 2016 May 5.

28.

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA.

JAMA Oncol. 2016 Aug 1;2(8):1023-9. doi: 10.1001/jamaoncol.2016.0386.

29.

Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.

Han PA, Kim HS, Cho S, Fazeli R, Najafian A, Khawaja H, McAlexander M, Dy B, Sorensen M, Aronova A, Sebo TJ, Giordano TJ, Fahey TJ 3rd, Thompson GB, Gauger PG, Somervell H, Bishop JA, Eshleman JR, Schneider EB, Witwer KW, Umbricht CB, Zeiger MA.

Thyroid. 2016 Apr;26(4):532-42. doi: 10.1089/thy.2015.0378. Epub 2016 Mar 7.

30.

Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency.

Turcu AF, Nanba AT, Chomic R, Upadhyay SK, Giordano TJ, Shields JJ, Merke DP, Rainey WE, Auchus RJ.

Eur J Endocrinol. 2016 May;174(5):601-9. doi: 10.1530/EJE-15-1181. Epub 2016 Feb 10.

31.

Molecular Heterogeneity in Aldosterone-Producing Adenomas.

Nanba K, Chen AX, Omata K, Vinco M, Giordano TJ, Else T, Hammer GD, Tomlins SA, Rainey WE.

J Clin Endocrinol Metab. 2016 Mar;101(3):999-1007. doi: 10.1210/jc.2015-3239. Epub 2016 Jan 14.

32.

An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma.

Papathomas TG, Pucci E, Giordano TJ, Lu H, Duregon E, Volante M, Papotti M, Lloyd RV, Tischler AS, van Nederveen FH, Nose V, Erickson L, Mete O, Asa SL, Turchini J, Gill AJ, Matias-Guiu X, Skordilis K, Stephenson TJ, Tissier F, Feelders RA, Smid M, Nigg A, Korpershoek E, van der Spek PJ, Dinjens WN, Stubbs AP, de Krijger RR.

Am J Surg Pathol. 2016 Apr;40(4):569-76. doi: 10.1097/PAS.0000000000000574.

33.

Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.

Duquette M, Sadow PM, Husain A, Sims JN, Antonello ZA, Fischer AH, Song C, Castellanos-Rizaldos E, Makrigiorgos GM, Kurebayashi J, Nose V, Van Hummelen P, Bronson RT, Vinco M, Giordano TJ, Dias-Santagata D, Pandolfi PP, Nucera C.

Oncotarget. 2015 Dec 15;6(40):42445-67. doi: 10.18632/oncotarget.6442.

34.

Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.

Giordano TJ.

Curr Opin Oncol. 2016 Jan;28(1):1-4. doi: 10.1097/CCO.0000000000000248. Review.

PMID:
26569424
35.

Notch signaling regulates gastric antral LGR5 stem cell function.

Demitrack ES, Gifford GB, Keeley TM, Carulli AJ, VanDussen KL, Thomas D, Giordano TJ, Liu Z, Kopan R, Samuelson LC.

EMBO J. 2015 Oct 14;34(20):2522-36. doi: 10.15252/embj.201490583. Epub 2015 Aug 12.

36.

Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.

Nishimoto K, Tomlins SA, Kuick R, Cani AK, Giordano TJ, Hovelson DH, Liu CJ, Sanjanwala AR, Edwards MA, Gomez-Sanchez CE, Nanba K, Rainey WE.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):E4591-9. doi: 10.1073/pnas.1505529112. Epub 2015 Aug 3.

37.

Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.

Goswami MT, Chen G, Chakravarthi BV, Pathi SS, Anand SK, Carskadon SL, Giordano TJ, Chinnaiyan AM, Thomas DG, Palanisamy N, Beer DG, Varambally S.

Oncotarget. 2015 Sep 15;6(27):23445-61.

38.

Assessing Biological Aggression in Adrenocortical Neoplasia.

Mouat IC, Giordano TJ.

Surg Pathol Clin. 2014 Dec;7(4):533-41. doi: 10.1016/j.path.2014.08.003. Epub 2014 Oct 6. Review.

PMID:
26837553
39.

Implications of the TCGA genomic characterization of papillary thyroid carcinoma for thyroid pathology: does follicular variant papillary thyroid carcinoma exist?

Asa SL, Giordano TJ, LiVolsi VA.

Thyroid. 2015 Jan;25(1):1-2. doi: 10.1089/thy.2014.0540. No abstract available.

PMID:
25409450
40.

The cancer genome atlas research network: a sight to behold.

Giordano TJ.

Endocr Pathol. 2014 Dec;25(4):362-5. doi: 10.1007/s12022-014-9345-4. No abstract available.

PMID:
25367656
41.

Histological insights into the pathogenesis of post-Roux-en-Y hyperinsulinaemic hypoglycaemia.

Lash RW, Giordano TJ, Moraitis AG, Hodish I.

Diabet Med. 2014 Dec;31(12):e29-32. doi: 10.1111/dme.12571.

42.

Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.

Giordano TJ.

Nat Rev Endocrinol. 2014 Aug;10(8):447-8. doi: 10.1038/nrendo.2014.89. Epub 2014 Jun 10. No abstract available.

PMID:
24913521
43.

Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens.

Giordano TJ, Beaudenon-Huibregtse S, Shinde R, Langfield L, Vinco M, Laosinchai-Wolf W, Labourier E.

Hum Pathol. 2014 Jul;45(7):1339-47. doi: 10.1016/j.humpath.2014.03.010. Epub 2014 Apr 4.

PMID:
24830619
44.

Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.

Basturk O, Tang L, Hruban RH, Adsay V, Yang Z, Krasinskas AM, Vakiani E, La Rosa S, Jang KT, Frankel WL, Liu X, Zhang L, Giordano TJ, Bellizzi AM, Chen JH, Shi C, Allen P, Reidy DL, Wolfgang CL, Saka B, Rezaee N, Deshpande V, Klimstra DS.

Am J Surg Pathol. 2014 Apr;38(4):437-47. doi: 10.1097/PAS.0000000000000169.

45.

Adrenocortical carcinoma.

Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD.

Endocr Rev. 2014 Apr;35(2):282-326. doi: 10.1210/er.2013-1029. Epub 2013 Dec 20. Review.

46.

Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancer.

Grabauskiene S, Bergeron EJ, Chen G, Thomas DG, Giordano TJ, Beer DG, Morgan MA, Reddy RM.

J Surg Res. 2014 Mar;187(1):6-13. doi: 10.1016/j.jss.2013.12.016. Epub 2013 Dec 18.

47.

CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells.

Grabauskiene S, Bergeron EJ, Chen G, Chang AC, Lin J, Thomas DG, Giordano TJ, Beer DG, Morgan MA, Reddy RM.

Lung Cancer. 2013 Dec;82(3):477-84. doi: 10.1016/j.lungcan.2013.09.010. Epub 2013 Sep 23.

48.

Funding anatomic pathology research: a retrospective analysis of an intramural funding mechanism.

McDaniel A, Fullen DR, Cho KR, Lucas DR, Giordano TJ, Greenson J, Lieberman AP, Kunju LP, Myers JL, Roh MH.

Arch Pathol Lab Med. 2013 Sep;137(9):1270-3. doi: 10.5858/arpa.2012-0546-OA.

PMID:
23991740
49.

Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.

Li C, Aragon Han P, Lee KC, Lee LC, Fox AC, Beninato T, Thiess M, Dy BM, Sebo TJ, Thompson GB, Grant CS, Giordano TJ, Gauger PG, Doherty GM, Fahey TJ 3rd, Bishop J, Eshleman JR, Umbricht CB, Schneider EB, Zeiger MA.

J Clin Endocrinol Metab. 2013 Sep;98(9):3702-12. doi: 10.1210/jc.2013-1584. Epub 2013 Aug 22.

PMID:
23969188
50.

An oncocytic adrenal tumour in a patient with Birt-Hogg-Dubé syndrome.

Raymond VM, Long JM, Everett JN, Caoili EM, Gruber SB, Stoffel EM, Giordano TJ, Hammer GD, Else T.

Clin Endocrinol (Oxf). 2014 Jun;80(6):925-7. doi: 10.1111/cen.12292. Epub 2013 Aug 5. No abstract available.

Supplemental Content

Loading ...
Support Center